Polyrizon (PLRZ) vs Sensus Healthcare (SRTS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Polyrizon (PLRZ) has outperformed Sensus Healthcare (SRTS) over the past year, gaining 144.0% versus a loss of 43.8%. Sensus Healthcare is the larger company by market cap ($37.2 million vs $22.6 million), about 1.6 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | PLRZ | SRTS |
|---|---|---|
| Share price | $9.31 | $2.26 |
| Market cap | $22.61M | $37.20M |
| 1-day change | -8.42% | -4.24% |
| YTD return | +9.66% | -43.22% |
| 1-year return | +143.97% | -43.78% |
| 5-year return | — | -63.55% |
| EPS (TTM) | $-4.97 | $-0.97 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $27.48M |
| Revenue growth (YoY) | — | -34.26% |
| Net income (latest FY) | $-3.33M | $-7.72M |
| Gross margin | — | 43.18% |
| Operating margin | — | -37.50% |
| Net margin | — | -28.09% |
| 52-week high | $18.20 | $5.49 |
| 52-week low | $2.88 | $2.14 |
| Distance from 52-week high | -48.85% | -58.83% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +138.05% |
| Average volume | 38.21K | 208.74K |
| Shares outstanding | 2.43M | 16.46M |
| Employees | 2 | 60 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- PLRZ has outperformed SRTS by 187.8 percentage points over the past year.
About Polyrizon
PLRZ stock →Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company uses its proprietary technology to develop its products comprising Capture and Contain, a barrier against a range of allergen particulates and viruses; and Trap and Target for nasal delivery of active pharmaceutical ingredients.
Health Care · Medical/Dental Instruments · 2 employees
About Sensus Healthcare
SRTS stock →Sensus Healthcare, Inc. operates as a medical device company that manufactures and sells radiation therapy devices to healthcare providers worldwide.
Health Care · Medical/Dental Instruments · 60 employees
PLRZ vs SRTS FAQ
Which is bigger, Polyrizon or Sensus Healthcare?
Sensus Healthcare (SRTS) is larger, with a market capitalization of $37.20M compared with $22.61M for Polyrizon (PLRZ).
Which stock has performed better over the past year, PLRZ or SRTS?
PLRZ returned +143.97% over the past 12 months, compared with -43.78% for SRTS (price return, excluding dividends). Past performance does not predict future results.
Are Polyrizon and Sensus Healthcare in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.